Drug Profile
Research programme: dopamine D3 receptor agonists - Pfizer
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class Aminopyridines
- Mechanism of Action Dopamine D3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Sexual function disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sexual-function-disorders in USA (PO)
- 26 Mar 2009 Preclinical trials in Sexual function disorders in USA (PO)